Different Trial Designs

  • Christopher J. Bulpitt
Part of the Developments in Biostatistics and Epidemiology book series (DBEP, volume 1)

Abstract

In the standard trial design a subject or patient is considered suitable for entry to the trial and is then randomized to a treatment group; each group receives a single treatment. A fixed number of persons enter the trial and are followed for a predetermined interval of time; treatment is stopped at the end of this period. Other trial designs have to be considered. The subject may be asked to take more than one treatment consecutively (cross-over trial), more than one treatment simultaneously (trial to detect an interaction between treatments), or more than one treatment consecutively and concurrently (cross-over trial to detect an interaction). The remaining design variations do not involve a fixed number of persons being entered. The standard trial, cross-over trial, trial to detect an interaction between treatments, and cross-over trial to detect an interaction are illustrated in figure 11-1 for four treatments A, B, C, and D.

Keywords

Placebo Sugar Arthritis Heroin Cough 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer Science+Business Media Dordrecht 1983

Authors and Affiliations

  • Christopher J. Bulpitt
    • 1
    • 2
    • 3
  1. 1.Department of Medical Statistics and EpidemiologyLondon School of Hygiene and Tropical MedicineLondonUK
  2. 2.Royal Postgraduate Medical SchoolLondonUK
  3. 3.Hammersmith HospitalLondonUK

Personalised recommendations